143 related articles for article (PubMed ID: 24758507)
1. [The current staging for uterine body malignancies and its importance for clinical practice].
Sehnal B; Benková K; Kmoníčková E; Driák D; Spůrková Z; Maxová K; Sláma J
Cesk Patol; 2014 Apr; 50(2):100-5. PubMed ID: 24758507
[TBL] [Abstract][Full Text] [Related]
2. [Current classification of malignant tumours in gynecological oncology--part II].
Sehnal B; Driák D; Kmonícková E; Dvorská M; Hosová M; Citterbart K; Halaska M; Kolarík D
Ceska Gynekol; 2011 Oct; 76(5):360-6. PubMed ID: 22132636
[TBL] [Abstract][Full Text] [Related]
3. Uterine sarcomas: a review.
D'Angelo E; Prat J
Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
[TBL] [Abstract][Full Text] [Related]
4. Staging of uterine sarcomas.
Tse KY; Crawford R; Ngan HY
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
[TBL] [Abstract][Full Text] [Related]
5. Uterine sarcomas.
Mbatani N; Olawaiye AB; Prat J
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey.
Durnali A; Tokluoğlu S; Özdemir N; Inanç M; Alkiş N; Zengin N; Sönmez ÖU; Küçüköner M;
Asian Pac J Cancer Prev; 2012; 13(5):1935-41. PubMed ID: 22901150
[TBL] [Abstract][Full Text] [Related]
7. [Current classification of malignant tumours in gynecological oncology--part I].
Sehnal B; Driák D; Kmonícková E; Dvorská M; Hosová M; Citterbart K; Halaska M; Kolarík D
Ceska Gynekol; 2011 Sep; 76(4):279-84. PubMed ID: 22026069
[TBL] [Abstract][Full Text] [Related]
8. Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology.
Page BR; Pappas L; Cooke EW; Gaffney DK
Int J Gynecol Cancer; 2012 May; 22(4):593-8. PubMed ID: 22343970
[TBL] [Abstract][Full Text] [Related]
9. Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma.
Giuntoli RL; Lessard-Anderson CR; Gerardi MA; Kushnir CL; Cliby WA; Metzinger DS; Gostout BS
Int J Gynecol Cancer; 2013 Jun; 23(5):869-76. PubMed ID: 23669444
[TBL] [Abstract][Full Text] [Related]
10. Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study.
Garg G; Shah JP; Liu JR; Bryant CS; Kumar S; Munkarah A; Morris RT
Int J Gynecol Cancer; 2010 Oct; 20(7):1201-6. PubMed ID: 20940535
[TBL] [Abstract][Full Text] [Related]
11. Uterine sarcomas: clinical presentation and MRI features.
Santos P; Cunha TM
Diagn Interv Radiol; 2015; 21(1):4-9. PubMed ID: 25347940
[TBL] [Abstract][Full Text] [Related]
12. Current concepts in the imaging of uterine sarcoma.
Tirumani SH; Ojili V; Shanbhogue AK; Fasih N; Ryan JG; Reinhold C
Abdom Imaging; 2013 Apr; 38(2):397-411. PubMed ID: 22699695
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of 80 cases with uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma in China, 1988-2007.
Gao Y; Meng H; Zhang Y; Jiao T; Hui N
Int J Clin Exp Pathol; 2014; 7(4):1616-24. PubMed ID: 24817958
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in uterine sarcoma.
Gadducci A
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):783-95. PubMed ID: 21764643
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the treatment of sarcomas in gynecology.
Lange SS; Novetsky AP; Powell MA
Discov Med; 2014 Sep; 18(98):133-40. PubMed ID: 25227754
[TBL] [Abstract][Full Text] [Related]
16. [The reasons of changes in revised staging for carcinoma of the vulva].
Sehnal B; Kmoníčková E; Maxová K; Koutníková H; Driák D; Neumannová H; Bolehovská P; Sláma J
Klin Onkol; 2013; 26(5):319-22. PubMed ID: 24107153
[TBL] [Abstract][Full Text] [Related]
17. Uterine leiomyosarcoma in asian patients: validation of the revised Federation of gynecology and obstetrics staging system and identification of prognostic classifiers.
Tan PS; Koh E; Pang C; Ong WS; Ngo L; Soh LT; Quek R; Chay WY; Ho TH; Tay SK; Chew SH; Lim-Tan SK; Khoo-Tan H; Lim SL; Busmanis I; Goh LK; Chia YN; Chia WK; Lim T
Oncologist; 2012; 17(10):1286-93. PubMed ID: 22829569
[TBL] [Abstract][Full Text] [Related]
18. Uterine sarcoma Part I-Uterine leiomyosarcoma: The Topic Advisory Group systematic review.
Wen KC; Horng HC; Wang PH; Chen YJ; Yen MS; Ng HT;
Taiwan J Obstet Gynecol; 2016 Aug; 55(4):463-71. PubMed ID: 27590365
[TBL] [Abstract][Full Text] [Related]
19. Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma.
Arita S; Kikkawa F; Kajiyama H; Shibata K; Kawai M; Mizuno K; Nagasaka T; Ino K; Nomura S
Int J Gynecol Cancer; 2005; 15(2):329-36. PubMed ID: 15823121
[TBL] [Abstract][Full Text] [Related]
20. Uterine sarcoma: a clinicopathological study of 93 cases.
González-Bosquet E; Martínez-Palones JM; González-Bosquet J; García Jiménez A; Xercavins J
Eur J Gynaecol Oncol; 1997; 18(3):192-5. PubMed ID: 9174834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
